Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The U.S. approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated rollout that could protect millions globally, but it's unclear how many can get it.

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...